-
1
-
-
0034235969
-
Potential interactions between alternative therapies and warfarin
-
Heck A, Dewitt B, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Phar 2000;57:1221-1227.
-
(2000)
Am J Health Syst Phar
, vol.57
, pp. 1221-1227
-
-
Heck, A.1
Dewitt, B.2
Lukes, A.L.3
-
2
-
-
0025081050
-
Protective effects of Danshen during myocardial ischemia and reperfusion: An isolated rat heart study
-
Zhou W, Ruigrok TJC. Protective effects of Danshen during myocardial ischemia and reperfusion: An isolated rat heart study. Am J Chin Med 1990;18:19-24.
-
(1990)
Am J Chin Med
, vol.18
, pp. 19-24
-
-
Zhou, W.1
Ruigrok, T.J.C.2
-
4
-
-
0025675817
-
Hypotensive action of salvia miltiorrhiza cell culture extract
-
Li CP, Yung KH, Chiu KW. Hypotensive action of salvia miltiorrhiza cell culture extract. Am J Chin Med 1990;18:157-166.
-
(1990)
Am J Chin Med
, vol.18
, pp. 157-166
-
-
Li, C.P.1
Yung, K.H.2
Chiu, K.W.3
-
5
-
-
0028695392
-
The effect of radix salviae miltiorrhizae composite and ligustrazine on lipid peroxidation in low density lipoprotein due to copper dichloride
-
Zhang X, Wu K, Kuang P, et al. The effect of radix salviae miltiorrhizae composite and ligustrazine on lipid peroxidation in low density lipoprotein due to copper dichloride. J Trad Chin Med 1994;14:292-297.
-
(1994)
J Trad Chin Med
, vol.14
, pp. 292-297
-
-
Zhang, X.1
Wu, K.2
Kuang, P.3
-
6
-
-
0023254872
-
Isolation and bioactivity of new tanshinones
-
Lee AR, Wu WL, Chang W, Lin C, King ML. Isolation and bioactivity of new tanshinones. J Nat Prod 1987;50:157-160.
-
(1987)
J Nat Prod
, vol.50
, pp. 157-160
-
-
Lee, A.R.1
Wu, W.L.2
Chang, W.3
Lin, C.4
King, M.L.5
-
7
-
-
0029025569
-
The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats
-
Chan K, Lo AC, Yeung JH, Woo KS. The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. J Pharm Pharmacol 1995;47:402-406.
-
(1995)
J Pharm Pharmacol
, vol.47
, pp. 402-406
-
-
Chan, K.1
Lo, A.C.2
Yeung, J.H.3
Woo, K.S.4
-
8
-
-
0034720558
-
Profound drop of cyclosporine A whole blood trough levels caused by St. John's wort
-
Breidenbach T, Kliem V, Burg M, Radermacher J, Hoffmann MW, Klempnauer J. Profound drop of cyclosporine A whole blood trough levels caused by St. John's wort [letter]. Transplantation 2000;69:2229-2230.
-
(2000)
Transplantation
, vol.69
, pp. 2229-2230
-
-
Breidenbach, T.1
Kliem, V.2
Burg, M.3
Radermacher, J.4
Hoffmann, M.W.5
Klempnauer, J.6
-
9
-
-
0034037813
-
Interactions between drugs and Asian medicines: Displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicine Chan Su and Lu-Shen-Wan
-
Datta P, Dasgupta A. Interactions between drugs and Asian medicines: Displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicine Chan Su and Lu-Shen-Wan. Ther Drug Monit 2000;22:155-159.
-
(2000)
Ther Drug Monit
, vol.22
, pp. 155-159
-
-
Datta, P.1
Dasgupta, A.2
-
10
-
-
0034843222
-
Positive and negative in vitro interference of Chinese medicine Danshen in serum digoxin measurement: Elimination of interference by monitoring free digoxin concentrations
-
Wahed A, Dasgupta A. Positive and negative in vitro interference of Chinese medicine Danshen in serum digoxin measurement: Elimination of interference by monitoring free digoxin concentrations. Am J Clin Pathol 2001;116:403-408.
-
(2001)
Am J Clin Pathol
, vol.116
, pp. 403-408
-
-
Wahed, A.1
Dasgupta, A.2
-
12
-
-
0024432794
-
Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid
-
Miners JO. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid. Clin Pharmacokinet 1989;17:327-344.
-
(1989)
Clin Pharmacokinet
, vol.17
, pp. 327-344
-
-
Miners, J.O.1
-
13
-
-
0028906743
-
Carbamazepine-salicylate interaction in normal and uremic sera: Reduced interaction in uremic sera
-
Dasgupta A, Thompson WC. Carbamazepine-salicylate interaction in normal and uremic sera: Reduced interaction in uremic sera. Ther Drug Monit 1995;17:199-202.
-
(1995)
Ther Drug Monit
, vol.17
, pp. 199-202
-
-
Dasgupta, A.1
Thompson, W.C.2
-
14
-
-
0001883759
-
Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALD1 mass spectrometric determination of molecular weight range of inhibitors
-
Biddel D, Wells A, Dasgupta A. Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALD1 mass spectrometric determination of molecular weight range of inhibitors. Life Sci 2000;66:143-151.
-
(2000)
Life Sci
, vol.66
, pp. 143-151
-
-
Biddel, D.1
Wells, A.2
Dasgupta, A.3
|